RCUS Arcus Biosciences, Inc. logo

RCUS Arcus Biosciences, Inc.

Healthcare
$23.43-1.84%ClosedMarket Cap: $2.36B

As of 2026-05-25

Insider Statistics (Q2 2026)

Acquisitions

0

Dispositions

1

Buy/Sell Ratio

0.00

Net Shares

-7,763

Shares Acquired

0

Shares Disposed

7,763

Total Bought ($)

$0.00

Total Sold ($)

$1.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Tue May 12Ribas AntonidirectorSell5,050$0.0038,600
Tue May 12Goeltz II Robert C.officer: Chief Financial OfficerSell7,763$25.6384,161
Mon Jan 26Tang Carolyn C.officer: General CounselSell96,000$22.1396,000
Mon Jan 26Tang Carolyn C.officer: General CounselSell24,000$0.00148,734
Mon Jan 26ROSEN TERRY Jdirector, officer: Chief Executive OfficerSell315,000$22.13315,000
Mon Jan 26ROSEN TERRY Jdirector, officer: Chief Executive OfficerSell79,000$0.002,236,409
Mon Jan 26Markus Richardofficer: Chief Medical OfficerSell96,000$22.1396,000
Mon Jan 26Markus Richardofficer: Chief Medical OfficerSell24,000$0.0089,647
Mon Jan 26Jaen Juan C.officer: PresidentSell126,000$22.13126,000
Mon Jan 26Jaen Juan C.officer: PresidentSell31,000$0.00377,012
Mon Jan 26Goeltz II Robert C.officer: Chief Financial OfficerSell96,000$22.1396,000
Mon Jan 26Goeltz II Robert C.officer: Chief Financial OfficerSell24,000$0.0091,924